156 related articles for article (PubMed ID: 34994855)
1. [Cytology of body cavity fluids - established methods and new developments].
Engels M
Pathologe; 2022 Mar; 43(2):91-98. PubMed ID: 34994855
[TBL] [Abstract][Full Text] [Related]
2. Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology.
Engels M; Michael C; Dobra K; Hjerpe A; Fassina A; Firat P
Cytopathology; 2019 Jan; 30(1):31-38. PubMed ID: 30430668
[TBL] [Abstract][Full Text] [Related]
3. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids.
Dadhich H; Toi PC; Siddaraju N; Sevvanthi K
Diagn Cytopathol; 2016 Nov; 44(11):874-879. PubMed ID: 27546351
[TBL] [Abstract][Full Text] [Related]
4. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
[TBL] [Abstract][Full Text] [Related]
5. [Cytological variations observed in the malignant cells in body cavity fluids].
Matsuda M
Rinsho Byori; 1990 Nov; Suppl 87():69-85. PubMed ID: 2287091
[No Abstract] [Full Text] [Related]
6. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
[TBL] [Abstract][Full Text] [Related]
7. Clinical, cytologic, and immunohistochemical features of sarcomas involving body cavity fluids.
Chen AL; Janko E; Pitman MB; Chebib I
Cancer Cytopathol; 2019 Dec; 127(12):778-784. PubMed ID: 31693303
[TBL] [Abstract][Full Text] [Related]
8. Analysis of diagnostic value of cytological smear method versus cell block method in body fluid cytology: study of 150 cases.
Bhanvadia VM; Santwani PM; Vachhani JH
Ethiop J Health Sci; 2014 Apr; 24(2):125-31. PubMed ID: 24795513
[TBL] [Abstract][Full Text] [Related]
9. Positive effusion cytology as the initial presentation of malignancy.
Monte SA; Ehya H; Lang WR
Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
[TBL] [Abstract][Full Text] [Related]
10. Review of the impact of the International System for Serous Fluid Cytopathology.
Mikou P; Pergaris A; Engels M; Chandra A
Cytopathology; 2024 Jan; 35(1):16-22. PubMed ID: 37795809
[TBL] [Abstract][Full Text] [Related]
11. Serous effusions in malignant lymphomas: a review.
Das DK
Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
[TBL] [Abstract][Full Text] [Related]
12. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.
Sundling KE; Cibas ES
Cancer Cytopathol; 2018 Aug; 126 Suppl 8():590-598. PubMed ID: 30156768
[TBL] [Abstract][Full Text] [Related]
13. Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology.
Bedrossian CW
Diagn Cytopathol; 1998 Feb; 18(2):141-9. PubMed ID: 9484644
[No Abstract] [Full Text] [Related]
14. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
Straccia P; Chiappetta M; Magnini D; Cancellieri A
Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
[TBL] [Abstract][Full Text] [Related]
15. Cytomorphology, clinicopathologic, and cytogenetics correlation of myelomatous effusion of serous cavities: A retrospective review.
Harbhajanka A; Brickman A; Park JW; Reddy VB; Bitterman P; Gattuso P
Diagn Cytopathol; 2016 Sep; 44(9):742-7. PubMed ID: 27434129
[TBL] [Abstract][Full Text] [Related]
16. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
[TBL] [Abstract][Full Text] [Related]
17. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
Pinto D; Chandra A; Crothers BA; Kurtycz DFI; Schmitt F
J Am Soc Cytopathol; 2020; 9(6):469-477. PubMed ID: 32620534
[TBL] [Abstract][Full Text] [Related]
18. Cytomorphology, Immunophenotype, and cytogenetic profile of leukemic serous effusions.
Kaur K; Patel T; Patra S; Trivedi P
Diagn Cytopathol; 2021 Aug; 49(8):948-958. PubMed ID: 33973738
[TBL] [Abstract][Full Text] [Related]
19. A Retrospective Analysis of the Application of the Newly Proposed International System for Reporting Serous Fluid Cytopathology on Serous Effusion Specimens: An Institutional Experience.
Rajeswaran PK; Srinivasan V; Mahesh SSV; Ashok AU
Acta Cytol; 2023; 67(1):70-79. PubMed ID: 36476509
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic significance of a cytological study of the fluids from serous cavities].
Bazarnova MA; Zakhariia EA; Sakun TL; Zaika IN; Pekus EN
Vrach Delo; 1984 Sep; (9):104-7. PubMed ID: 6506626
[No Abstract] [Full Text] [Related]
[Next] [New Search]
